$900 Million is the total value of Soleus Capital Management, L.P.'s 101 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 70.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $53,583,751 | +75.6% | 242,735 | +78.2% | 5.96% | +88.5% |
| EDAP | Buy | EDAP TMS S Asponsored adr | $50,472,327 | -14.2% | 5,474,222 | +3.0% | 5.61% | -7.9% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $44,046,534 | +39.8% | 209,496 | +34.2% | 4.90% | +50.1% |
| SRDX | Buy | SURMODICS INC | $41,856,398 | +105.8% | 1,336,838 | +49.8% | 4.65% | +120.9% |
| ORGO | Buy | ORGANOGENESIS HLDGS INC | $38,937,169 | +85.5% | 11,728,063 | +19.0% | 4.33% | +99.2% |
| IRMD | IRADIMED CORP | $36,936,152 | +21.3% | 773,694 | 0.0% | 4.11% | +30.2% | |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $32,002,500 | – | 4,250,000 | +100.0% | 3.56% | – |
| Sell | ARCELLX INC | $31,683,208 | -17.6% | 1,001,999 | -19.7% | 3.52% | -11.6% | |
| PCVX | Buy | VAXCYTE INC | $28,528,225 | +100.2% | 571,250 | +50.2% | 3.17% | +114.8% |
| HUM | Buy | HUMANA INC | $28,057,408 | +143.3% | 62,750 | +164.2% | 3.12% | +161.2% |
| CVS | Buy | CVS HEALTH CORP | $24,544,883 | +35.6% | 355,054 | +45.8% | 2.73% | +45.6% |
| CELC | Buy | CELCUITY INC | $21,117,647 | +22.1% | 1,923,283 | +13.9% | 2.35% | +31.0% |
| SKIN | Buy | THE BEAUTY HEALTH COMPANY | $20,772,574 | +50.9% | 2,481,789 | +127.7% | 2.31% | +61.9% |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $18,289,639 | +8.2% | 14,178,015 | +10.7% | 2.03% | +16.2% |
| SIBN | Sell | SI-BONE INC | $16,893,365 | -19.1% | 626,144 | -41.0% | 1.88% | -13.1% |
| AXGN | Buy | AXOGEN INC | $16,342,682 | -2.8% | 1,789,998 | +0.6% | 1.82% | +4.3% |
| SNN | Sell | SMITH & NEPHEW PLCspdn adr new | $15,778,893 | -41.7% | 489,268 | -49.6% | 1.75% | -37.4% |
| SGEN | SEAGEN INC | $13,664,660 | -4.9% | 71,000 | 0.0% | 1.52% | +2.0% | |
| BCAB | BIOATLA INC | $12,963,591 | +11.9% | 4,321,197 | 0.0% | 1.44% | +20.2% | |
| KRYS | Buy | KRYSTAL BIOTECH INC | $12,936,541 | +89.7% | 110,192 | +29.4% | 1.44% | +103.7% |
| INBX | Buy | INHIBRX INC | $12,283,831 | +48.6% | 473,183 | +8.0% | 1.37% | +59.6% |
| EPIX | Buy | ESSA PHARMA INC | $11,345,654 | -7.8% | 4,202,094 | +1.4% | 1.26% | -1.1% |
| NPCE | Buy | NEUROPACE INC | $11,073,301 | -1.7% | 2,466,214 | +1.5% | 1.23% | +5.5% |
| TGTX | Sell | TG THERAPEUTICS INC | $10,817,820 | -4.1% | 435,500 | -42.0% | 1.20% | +2.9% |
| Buy | JASPER THERAPEUTICS INC | $10,653,093 | -21.1% | 7,775,980 | +4.3% | 1.18% | -15.2% | |
| BCYC | BICYCLE THERAPEUTICS PLCsponsored ads | $10,509,136 | +20.0% | 411,800 | 0.0% | 1.17% | +28.8% | |
| NVCR | Buy | NOVOCURE LTD | $10,171,650 | +30.1% | 245,100 | +88.5% | 1.13% | +39.6% |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $9,945,892 | -37.3% | 97,547 | -44.1% | 1.11% | -32.7% |
| MCRB | New | SERES THERAPEUTICS INC | $9,800,259 | – | 2,045,983 | +100.0% | 1.09% | – |
| BHC | New | BAUSCH HEALTH COS INC | $9,244,000 | – | 1,155,500 | +100.0% | 1.03% | – |
| Sell | NUVALENT INC | $8,982,210 | +45.3% | 213,000 | -10.1% | 1.00% | +56.1% | |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $8,728,030 | -1.5% | 1,239,777 | -14.5% | 0.97% | +5.8% |
| ILMN | New | ILLUMINA INC | $8,605,791 | – | 45,900 | +100.0% | 0.96% | – |
| NTRA | Sell | NATERA INC | $8,213,808 | -49.7% | 168,800 | -42.6% | 0.91% | -46.0% |
| ANGO | Buy | ANGIODYNAMICS INC | $8,015,455 | +244.5% | 768,500 | +241.6% | 0.89% | +269.7% |
| THTX | Buy | THERATECHNOLOGIES INC | $7,845,077 | +6.5% | 9,325,511 | +2.6% | 0.87% | +14.3% |
| CCCC | Buy | C4 THERAPEUTICS INC | $7,403,055 | -1.2% | 2,692,020 | +12.8% | 0.82% | +6.1% |
| EOLS | New | EVOLUS INC | $7,393,590 | – | 1,017,000 | +100.0% | 0.82% | – |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $7,316,531 | – | 519,640 | +100.0% | 0.81% | – |
| EXAS | Sell | EXACT SCIENCES CORP | $6,526,050 | -78.9% | 69,500 | -84.8% | 0.72% | -77.4% |
| BBIO | BRIDGEBIO PHARMA INC | $6,260,800 | +3.7% | 364,000 | 0.0% | 0.70% | +11.4% | |
| TMDX | Buy | TRANSMEDICS GROUP INC | $6,231,316 | +333.1% | 74,200 | +290.5% | 0.69% | +365.1% |
| ALKS | Sell | ALKERMES PLC | $6,084,720 | -6.2% | 194,400 | -15.5% | 0.68% | +0.7% |
| PHVS | Buy | PHARVARIS N V | $5,933,366 | +118.6% | 391,900 | +16.3% | 0.66% | +134.9% |
| New | TANGO THERAPEUTICS INC | $5,899,298 | – | 1,776,897 | +100.0% | 0.66% | – | |
| VKTX | Sell | VIKING THERAPEUTICS INC | $5,457,907 | -28.7% | 336,700 | -26.8% | 0.61% | -23.5% |
| New | XERIS BIOPHARMA HOLDINGS INC | $5,381,755 | – | 2,054,105 | +100.0% | 0.60% | – | |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $5,059,360 | – | 307,000 | +100.0% | 0.56% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $5,010,104 | – | 57,800 | +100.0% | 0.56% | – |
| MIRM | Sell | MIRUM PHARMACEUTICALS INC | $4,553,120 | -21.7% | 176,000 | -27.3% | 0.51% | -15.9% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $4,449,718 | -34.7% | 212,600 | -34.1% | 0.50% | -29.9% |
| ETNB | Sell | 89BIO INC | $4,292,175 | -43.0% | 226,500 | -54.1% | 0.48% | -38.8% |
| New | GENEDX HOLDINGS CORP | $4,239,920 | – | 711,396 | +100.0% | 0.47% | – | |
| DXCM | New | DEXCOM INC | $4,240,830 | – | 33,000 | +100.0% | 0.47% | – |
| CBAY | New | CYMABAY THERAPEUTICS INC | $4,084,350 | – | 373,000 | +100.0% | 0.45% | – |
| FDMT | Sell | 4D MOLECULAR THERAPEUTICS IN | $3,960,004 | -50.9% | 219,148 | -53.3% | 0.44% | -47.4% |
| New | VERASTEM INC | $3,871,545 | – | 520,369 | +100.0% | 0.43% | – | |
| Sell | DICE THERAPEUTICS INC | $3,716,800 | -25.2% | 80,000 | -53.9% | 0.41% | -19.8% | |
| NSPR | New | INSPIREMD INC | $3,459,101 | – | 1,378,128 | +100.0% | 0.38% | – |
| IMVT | New | IMMUNOVANT INC | $3,293,173 | – | 173,599 | +100.0% | 0.37% | – |
| TWST | New | TWIST BIOSCIENCE CORP | $3,273,600 | – | 160,000 | +100.0% | 0.36% | – |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $3,066,259 | -50.0% | 14,140 | -58.1% | 0.34% | -46.3% |
| KROS | Sell | KEROS THERAPEUTICS INC | $2,844,744 | -45.5% | 70,800 | -42.1% | 0.32% | -41.6% |
| Buy | AMYLYX PHARMACEUTICALS INC | $2,588,400 | +39.6% | 120,000 | +89.8% | 0.29% | +50.0% | |
| XENE | New | XENON PHARMACEUTICALS INC | $2,541,000 | – | 66,000 | +100.0% | 0.28% | – |
| GLTO | New | GALECTO INC | $2,520,000 | – | 1,000,000 | +100.0% | 0.28% | – |
| VCEL | Sell | VERICEL CORP | $2,519,031 | -73.7% | 67,049 | -79.5% | 0.28% | -71.7% |
| LYRA | LYRA THERAPEUTICS INC | $2,434,834 | +104.5% | 592,417 | 0.0% | 0.27% | +120.3% | |
| PRAX | New | PRAXIS PRECISION MEDICINES I | $2,415,000 | – | 2,100,000 | +100.0% | 0.27% | – |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $2,380,336 | – | 42,400 | +100.0% | 0.26% | – |
| New | AADI BIOSCIENCE INC | $2,279,273 | – | 333,227 | +100.0% | 0.25% | – | |
| BDTX | New | BLACK DIAMOND THERAPEUTICS I | $2,196,750 | – | 435,000 | +100.0% | 0.24% | – |
| ANNX | Sell | ANNEXON INC | $2,183,808 | -38.0% | 620,400 | -32.2% | 0.24% | -33.4% |
| INSP | Sell | INSPIRE MED SYS INC | $2,175,088 | -40.4% | 6,700 | -57.1% | 0.24% | -36.0% |
| LLY | New | LILLY ELI & CO | $2,016,614 | – | 4,300 | +100.0% | 0.22% | – |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $1,789,314 | +40.1% | 24,900 | +20.3% | 0.20% | +50.8% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $1,580,700 | -55.8% | 66,000 | -65.3% | 0.18% | -52.4% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $1,565,870 | -22.3% | 151,000 | -39.4% | 0.17% | -16.7% |
| CERE | Sell | CEREVEL THERAPEUTICS HLDNG I | $1,462,340 | -61.3% | 46,000 | -70.3% | 0.16% | -58.3% |
| LQDA | New | LIQUIDIA CORPORATION | $1,373,750 | – | 175,000 | +100.0% | 0.15% | – |
| Sell | MINERALYS THERAPEUTICS INC | $1,309,730 | -69.4% | 76,817 | -71.9% | 0.15% | -67.0% | |
| RCEL | New | AVITA MEDICAL INC | $1,275,750 | – | 75,000 | +100.0% | 0.14% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $1,099,276 | – | 39,800 | +100.0% | 0.12% | – |
| YMAB | Buy | Y-MABS THERAPEUTICS INC | $1,067,266 | +144.3% | 157,182 | +80.3% | 0.12% | +164.4% |
| IMCR | New | IMMUNOCORE HLDGS PLCads | $983,344 | – | 16,400 | +100.0% | 0.11% | – |
| ALPN | New | ALPINE IMMUNE SCIENCES INC | $905,390 | – | 88,073 | +100.0% | 0.10% | – |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $808,860 | – | 34,000 | +100.0% | 0.09% | – |
| MORF | New | MORPHIC HLDG INC | $779,688 | – | 13,600 | +100.0% | 0.09% | – |
| IMUX | IMMUNIC INC | $753,000 | +68.5% | 300,000 | 0.0% | 0.08% | +82.6% | |
| New | VENTYX BIOSCIENCES INC | $698,640 | – | 21,300 | +100.0% | 0.08% | – | |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $636,514 | – | 38,600 | +100.0% | 0.07% | – |
| PLRX | New | PLIANT THERAPEUTICS INC | $607,020 | – | 33,500 | +100.0% | 0.07% | – |
| XILIO THERAPEUTICS INC | $594,585 | -17.4% | 226,941 | 0.0% | 0.07% | -10.8% | ||
| LUNG | Sell | PULMONX CORP | $537,510 | -32.3% | 41,000 | -42.3% | 0.06% | -26.8% |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $508,800 | – | 320,000 | +100.0% | 0.06% | – |
| VRNA | New | VERONA PHARMA PLCsponsored ads | $458,738 | – | 21,700 | +100.0% | 0.05% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $461,448 | – | 13,600 | +100.0% | 0.05% | – |
| New | INDIVIOR PLCord | $443,251 | – | 18,624 | +100.0% | 0.05% | – | |
| TVTX | Sell | TRAVERE THERAPEUTICS INC | $331,776 | -93.7% | 21,600 | -90.8% | 0.04% | -93.2% |
| Sell | PARAGON 28 INC | $177,400 | -94.9% | 10,000 | -95.1% | 0.02% | -94.5% | |
| STRO | New | SUTRO BIOPHARMA INC | $120,375 | – | 25,887 | +100.0% | 0.01% | – |
| Exit | MDXHEALTH SAsponsored ads | $0 | – | -60,000 | -100.0% | -0.02% | – | |
| Exit | ORCHESTRA BIOMED HLDGS INC | $0 | – | -60,450 | -100.0% | -0.12% | – | |
| Exit | RXSIGHT INC | $0 | – | -80,000 | -100.0% | -0.14% | – | |
| Exit | PARDES BIOSCIENCES INC | $0 | – | -1,250,000 | -100.0% | -0.17% | – | |
| CSII | Exit | CARDIOVASCULAR SYS INC DEL | $0 | – | -95,346 | -100.0% | -0.20% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -129,463 | -100.0% | -0.25% | – |
| ABCM | Exit | ABCAM PLCads | $0 | – | -279,971 | -100.0% | -0.39% | – |
| PIRS | Exit | PIERIS PHARMACEUTICALS INC | $0 | – | -4,134,868 | -100.0% | -0.42% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS INC | $0 | – | -116,514 | -100.0% | -0.49% | – |
| NARI | Exit | INARI MED INC | $0 | – | -101,450 | -100.0% | -0.65% | – |
| Exit | GENEDX HOLDINGS CORP | $0 | – | -17,940,000 | -100.0% | -0.68% | – | |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -203,300 | -100.0% | -0.86% | – |
| LNTH | Exit | LANTHEUS HLDGS INC | $0 | – | -113,700 | -100.0% | -0.97% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -2,127,043 | -100.0% | -5.36% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -2,080,000 | -100.0% | -16.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
| IRADIMED CORP | 16 | Q3 2023 | 5.8% |
| XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
| IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
| SURMODICS INC | 14 | Q3 2023 | 4.7% |
| NATERA INC | 13 | Q3 2023 | 3.9% |
| DEXCOM INC | 13 | Q2 2023 | 4.2% |
| NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
| CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
| LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.